Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 5
2011 8
2012 6
2013 9
2014 6
2015 5
2016 8
2017 3
2018 4
2019 1
2020 4
2021 6
2022 2
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, Pedersen SD, Pietiläinen KH, Rubino D, Batterham RL. Lau DCW, et al. Lancet. 2021 Dec 11;398(10317):2160-2172. doi: 10.1016/S0140-6736(21)01751-7. Epub 2021 Nov 16. Lancet. 2021. PMID: 34798060 Clinical Trial.
Pramlintide for post-bariatric hypoglycaemia.
Sheehan A, Goldfine A, Bajwa M, Wolfs D, Kozuka C, Piper J, Fowler K, Patti ME. Sheehan A, et al. Diabetes Obes Metab. 2022 Jun;24(6):1021-1028. doi: 10.1111/dom.14665. Epub 2022 Mar 9. Diabetes Obes Metab. 2022. PMID: 35137513 Free PMC article.
GLP-1 and Amylin in the Treatment of Obesity.
Jorsal T, Rungby J, Knop FK, Vilsbøll T. Jorsal T, et al. Curr Diab Rep. 2016 Jan;16(1):1. doi: 10.1007/s11892-015-0693-3. Curr Diab Rep. 2016. PMID: 26699764 Review.
Long-acting amylin analogues for the management of obesity.
Mathiesen DS, Bagger JI, Knop FK. Mathiesen DS, et al. Curr Opin Endocrinol Diabetes Obes. 2022 Apr 1;29(2):183-190. doi: 10.1097/MED.0000000000000716. Curr Opin Endocrinol Diabetes Obes. 2022. PMID: 35066542 Review.
63 results